Updates from The Motley Fool

Latest updates on Alimera Sciences, Inc. from Fool.com.


Stock Performance

ALIM vs. S&P 500 | 2 Year Performance
ALIM 1-Day Stock Chart
ALIM 5-Day Stock Chart
ALIM 1-Month Stock Chart
ALIM 3-Month Stock Chart
ALIM 6-Month Stock Chart
ALIM 1-Year Stock Chart
ALIM 2-Year Stock Chart
ALIM 5-Year Stock Chart
View Interactive ALIM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alimera Sciences, Inc. .
Current Price: $2.22
Prev Close: $2.36
Open: $2.37
Bid: $2.20
Ask: $4.50
Day's Range: $2.20 - $2.38
52wk Range: $1.49 - $5.15
Volume: 193,060
Avg Vol 307,904
Market Cap: $98.89M
P/E (ttm): -3.42
EPS (ttm): -$0.69
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alimera Sciences, Inc. .
CAPS Rating 1 out of 5
 
62 Outperform
16 Underperform
CAPS All Stars
 
5 Outperform
8 Underperform

How do you think Alimera Sciences, Inc. will perform against the market?



You pick for Alimera Sciences, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

C. Daniel Myers, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alimera Sciences, Inc. .

Alimera Sciences Inc. is a biopharmaceutical company that engaged in the research development and commercialization of ophthalmic pharmaceuticals.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers